Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia

References

• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–55.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, . Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237–48.
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:481–98.
   PubMed Web of Science ®Google Scholar
• Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000;38:542–6.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement. CLSI document M100-S20. Wayne, PA: 2010.
   Google Scholar
• Schwaber MJ, Raney PM, Rasheed JK, Biddle JW, Williams P, McGowan JE Jr, . Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non- Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol 2004;42:294–8.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. CLSI document M100-S17. Wayne, PA: CLSI; 2008.
   Google Scholar
• Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008;14(Suppl 1):90–103.
   PubMedGoogle Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657–86.
   PubMed Web of Science ®Google Scholar
• Szabo D, Bonomo RA, Silveira F, Pasculle AW, Baxter C, Linden PK, . SHV-type extended-spectrum beta- lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae. J Clin Microbiol 2005; 43:5058–64.
   PubMed Web of Science ®Google Scholar
• Endimiani A, Luzzaro F, Perilli M, Lombardi G, Coli A, Tamborini A, . Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Clin Infect Dis 2004;38:243–51.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, . Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206–12.
   PubMed Web of Science ®Google Scholar
• Ho PL, Chan WM, Tsang KW, Wong SS, Young K. Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case–control study of risk factors and outcomes. Scand J Infect Dis 2002;34:567–73.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957–63.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Bryant T. Confidence interval analysis. 2.1.2 ed. Southampton, UK: University of Southampton; 2000.
   Google Scholar
• Pai H, Hong JY, Byeon JH, Kim YK, Lee HJ. High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob Agents Chemother 2004; 48:3159–61.
   PubMed Web of Science ®Google Scholar
• Choi SH, Lee JE, Park SJ, Kim MN, Choo EJ, Kwak YG, . Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea. Eur J Clin Microbiol Infect Dis 2007;26:557–61.
   PubMed Web of Science ®Google Scholar
• Towne TG, Lewis JS 2nd, Herrera M, Wickes B, Jorgensen JH. Detection of SHV-type extended-spectrum beta- lactamase in Enterobacter isolates. J Clin Microbiol 2010; 48:298–9.
   Google Scholar
• Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, . Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 2008;62:133–6.
   PubMed Web of Science ®Google Scholar
• Yang JL, Wang JT, Lauderdale TL, Chang SC. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production. J Microbiol Immunol Infect 2009;42:310–6.
   PubMedGoogle Scholar
• Wiegand I, Geiss HK, Mack D, Sturenburg E, Seifert H. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 2007;45:1167–74.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, . Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473–8.
   PubMed Web of Science ®Google Scholar
• Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, . Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46:1481–91.
   PubMed Web of Science ®Google Scholar
• Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, . Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002;28:1718–23.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, . Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004;39:31–7.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257–62.
   PubMed Web of Science ®Google Scholar